Virology And HIVAIDS Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Virology and HIVAIDS

With the continuous emergence of new and evolving viral strains, virologists continue to play a critical role in advancing our understanding of viral diseases and developing innovative strategies for their prevention, diagnosis, and treatment. Among the most significant viral pathogens is Human Immunodeficiency Virus (HIV-1), a retrovirus responsible for Acquired Immunodeficiency Syndrome (AIDS), which primarily attacks the body's immune system. Despite remarkable progress in antiretroviral therapy (ART), HIV remains a major global public health challenge. While ART has dramatically reduced HIV-related mortality and improved the quality of life for millions, ongoing research is essential to achieve a functional cure, develop effective vaccines, and eliminate new infections.

We invite researchers, clinicians, healthcare professionals, and industry experts to join us in sharing their latest findings, innovations, and perspectives on this important and evolving field. Topics including HIV pathogenesis, antiviral drug development, vaccine research, diagnostic technologies, prevention strategies, and global public health initiatives will be central to the discussion.

Market Analysis:
The global HIV diagnostics market continues to experience strong growth, driven by increasing awareness, expanded screening programs, and technological advancements in diagnostic platforms. As of 2026, the market is estimated to be valued at approximately USD 3.6 billion and is projected to surpass USD 5.8 billion by 2031, growing at a compound annual growth rate (CAGR) of approximately 10% during the forecast period. This growth is largely attributed to the widespread adoption of point-of-care (POC) testing, rapid self-testing kits, molecular diagnostic technologies, and multiplex testing platforms capable of detecting multiple infectious diseases simultaneously.

In addition, global initiatives led by organizations such as UNAIDS, the World Health Organization (WHO), and national public health agencies continue to expand HIV testing and treatment programs, supporting the global goal of ending the HIV/AIDS epidemic as a public health threat. Increasing investments in research and development, digital health integration, and improved access to diagnostic services in low- and middle-income countries are further accelerating market growth and driving innovation across the HIV diagnostics landscape.

Tracks